Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery [Phase 2]
A Phase 2 clinical trial update focusing on reducing bleeding-related adverse events in patients undergoing plastic and reconstructive surge…
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients [Phase 2]
Phase 2 trial comparing fixed versus weight-based enoxaparin dosing in thoracic surgery patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) [Phase 3]
Open-label Phase 3 trial comparing dabigatran etexilate to standard of care in paediatric venous thromboembolism completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Safety of Dabigatran Etexilate in Blood Clot Prevention in Children [Phase 3]
Phase 3 trial assessing safety of dabigatran etexilate for venous thromboembolism prevention in children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
A completed clinical trial update on secondary prevention of acute venous thromboembolism; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis [Phase 3]
Phase 3 trial update for EINSTEIN Junior assessing oral rivaroxaban in children with venous thromboembolism has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy [Phase 2]
Phase 2 trial comparing oral apixaban to enoxaparin for thromboprophylaxis in women with suspected pelvic malignancy; results completed with…
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: PREvention of VENous ThromboEmbolism Following Radical Prostatectomy [Phase 4]
A Phase 4 clinical trial investigating prevention of venous thromboembolism after radical prostatectomy was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study [Phase 2]
Pilot Phase 2 trial evaluating statins for reducing venous thromboembolism events.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism [NA]
A completed clinical trial evaluating intermittent pneumatic compression in surgical patients at extremely high risk for venous thromboembol…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban [Phase 4]
A phase 4 trial comparing enoxaparin to rivaroxaban for preventing deep vein thrombosis is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Education Bundle to Decrease Patient Refusal of VTE Prophylaxis [NA]
A completed clinical trial evaluating an education bundle to reduce patient refusal of venous thromboembolism prophylaxis.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Sickle Cell Trait and the Risk of Venous Thromboembolism
Termination of a clinical trial evaluating sickle cell trait and risk of venous thromboembolism; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism [Phase 3]
Phase 3 trial comparing apixaban to dalteparin for reducing blood clots in cancer-associated venous thromboembolism has completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma [Phase 4]
Phase 4 trial update on apixaban for primary prevention of venous thromboembolism in patients with multiple myeloma; results have been poste…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) [Phase 4]
Phase 4 trial in Chinese patients evaluating oral anticoagulants for prevention of venous thromboembolism after lower extremity ankle fractu…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Aspirin and Enoxaparin for VTE in Trauma [Phase 4]
Phase 4 clinical trial investigating aspirin and enoxaparin for venous thromboembolism prevention in trauma patients has been terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing management of platelet transfusion therapy in patients with blood cancers or treatment-induced thrombocytop…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: ODEN Trial: Option vs. Denali IVC Filters [NA]
A terminated randomized trial comparing ODEN and Denali inferior vena cava filters for venous thromboembolism; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism [Phase 4]
A Phase 4 trial comparing oral anticoagulants for extended venous thromboembolism was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin [EARLY_Phase 1]
A Phase Early 1 trial evaluating anti-Xa level monitoring in surgery patients on fixed-dose heparin has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Thromboprophylaxis After Surgery for Gynecologic Malignancy in China [Phase 3]
Phase 3 trial assessing thromboprophylaxis after gynecologic cancer surgery in China; completed study on venous thromboembolism prevention w…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism [Phase 3]
A Phase 3 trial evaluating dabigatran etexilate as the primary treatment for malignancy-associated venous thromboembolism is underway, with …
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Improving Anticoagulation Control in VISN 1 [NA]
A completed clinical trial update from VA exploring improved anticoagulation control for patients using anticoagulants, including those with…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients [Phase 2]
Phase 2 clinical trial update for Fragmin (dalteparin) in treating acute venous thromboembolism in pediatric cancer patients has completed w…